Varian Medical Systems is committed to providing investors with accurate and timely information necessary for understanding the management, policies, operations, and performance of our company.
This is essential for establishing fruitful relationships based on mutual trust and respect with investors as well as our customers, employees, partners, patients and the public at large.
18 examples of the Agera R were produced during that time.It is in that spirit that we offer the information on this corporate governance site.Futhermore, interested parties wishing to communicate with our Board of Directors may do so through our Lead Director by sending an email to [email protected] therapy offers unique advantages that make it especially effective at treating a wide range of tumors.Using beams of positively charged nuclear particles, it delivers highly focused doses in the tumor, while potentially sparing healthy surrounding tissue.
Visit Varian's Patient Information web site to learn more about your treatment options, what to expect during treatment, FAQs, and even patient stories.
All designed to help you make informed decisions that impact you or your loved ones in the fight against cancer.
The Spot ON blog is intended to offer subscribers the latest news about Varian's proton therapy technology, information about new system and technological developments, system deployments around the world, and research in the field of proton therapy.
A Clear View— Read about the latest industry trends, technical tips from our technical experts, product news and announcements from our marketing team, legal and regulatory topics, business news, and much more!
The Agera R built upon the features and functionality of the Agera with new, unique solutions to enhance both performance and visual appearance even further.
Enhancements included: visible carbon on the front bonnet and bumper, new front side winglets, an all-new Aero exhaust, increased engine power with a raised RPM limit.